The Global Cardiovascular Drugs Market to Decline at a CAGR of 10.47 Percent Over the Period 2012-2016
DUBLIN, August 8, 2013 /PRNewswire/ –
Research and Markets (http://www.researchandmarkets.com/research/f5rg4j/global)
has announced the addition of the “Global Cardiovascular Drugs Market 2012-2016″
[http://www.researchandmarkets.com/research/f5rg4j/global ] report to their offering.
One of the key factors affecting market growth is the over-dependency of the market on
the US. The Global Cardiovascular Drugs market has also been witnessing an increase in R&D
activities. However, the increase in healthcare expenditure could be one of the factors
that will contribute to the growth of this market.
The key vendors dominating this market space are AstraZeneca plc, Bristol-Myers Squibb
Co., Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi.
The other vendors mentioned in the report are Abbott Laboratories, Forest Laboratories
Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Daiichi Sankyo Co. Ltd., GlaxoSmithKline plc,
Solvay SA, Takeda Pharmaceutical Co. Ltd., and The Medicines Co.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: “In the
last few years, the Healthcare industry has witnessed phenomenal growth in the APAC
region. Emerging economies such as the APAC region, Eastern Europe, and Latin America hold
vast growth potential. These regions are under-equipped to address the increase in the
incidence of CVDs in the region. However, the increase in the incidence of CVDs and
instances of patients frequently enduring long waits for therapeutic treatments are
forcing healthcare organizations in the region to opt for cardiovascular drugs. Moreover,
there has been substantial investment to initiate a significant number of projects in R&D
across the developing countries. Hence, healthcare organizations in developing regions
such as the APAC region and the Middle East are opting for cardiovascular drugs in
accordance with the demand in specific countries. The increasing demand for cardiovascular
drugs in the developing countries is boosting the growth of the global cardiovascular
drugs [http://www.researchandmarkets.com/research/f5rg4j/global ] market.”
Companies Mentioned - AstraZeneca plc - Bristol-Myers Squibb Co. - Merck & Co. Inc. - Novartis AG - Pfizer Inc. - Sanofi. - Abbott Laboratories - Forest Laboratories Inc. - F. Hoffmann-La Roche Ltd. - Bayer AG - Daiichi Sankyo Co. Ltd. - GlaxoSmithKline plc - Solvay SA - Takeda Pharmaceutical Co. Ltd. - The Medicines Co.
For more information visit
About Research and Markets
Research and Markets is the world’s leading source for international market research
reports and market data. We provide you with the latest data on international and regional
markets, key industries, the top companies, new products and the latest trends.
Research and Markets Laura Wood, Senior Manager. email@example.com U.S. Fax: +1-646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Cardiovascular Devices [http://www.researchandmarkets.com/categories.asp?cat_id=233&campaign_id=f5rg4j ]
SOURCE Research and Markets